{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:55:07Z","timestamp":1792446907847,"version":"4.5.0"},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the prevalence of metabolic associated steatotic liver disease (MASLD) in patients with primary aldosteronism (PA) compared to benign adrenal adenomas, and to evaluate the impact of hormonal excess in inducing MASLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Single\u2010centre retrospective study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Hepatic steatosis was assessed by liver\/spleen (L\/S) ratio from unenhanced abdomen computed tomography images (reference value\u2009&lt;\u20091.1) in a cohort of 41 patients with PA without cortisol cosecretion, 20 unilateral (uPA) and 21 bilateral (BPA), 50 with nonfunctioning adrenal incidentalomas (NF\u2010AI), 48 with mild autonomous cortisol secretion (MACS) and 10 with adrenal Cushing Syndrome (CS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Hepatic steatosis was increased in patients with PA at diagnosis: L\/S ratio was lower in PA than NF\u2010AI (1.1 vs. 1.25, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and MACS (1.1 vs. 1.21, p 0.007), but was similar to adrenal CS (1.1 vs. 1.15, <jats:italic>p<\/jats:italic>\u2009=\u20090.147). A improvement in L\/S ratio after medical or surgical treatment was observed in PA patients, resulting in reduced liver steatosis. MASLD prevalence was higher in PA compared to MACS (49% vs. 25%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and NF\u2010AI (49% vs. 14%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), but similar to CS (49% vs. 45%, <jats:italic>p<\/jats:italic>\u2009=\u20090.61). uPA patients had higher MASLD prevalence compared to BPA group 71% (53%\u201389%) versus 25% (7%\u201343%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Prevalence of MASLD was increased in PA (higher in uPA than BPA) compared to MACS and NFAI, and similar to adrenal CS.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.15231","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:10:48Z","timestamp":1741867848000},"page":"618-625","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Metabolic\u2010Associated Steatotic Liver Disease in Patients With Primary Aldosteronism"],"prefix":"10.1111","volume":"102","author":[{"given":"Irene","family":"Tizianel","sequence":"first","affiliation":[{"name":"Department of Medicine DIMED Endocrine Unit Padua Italy"},{"name":"Endocrine Unit, University\u2010Hospital of Padova Padua Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Madinelli","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED Endocrine Unit Padua Italy"},{"name":"Endocrine Unit, University\u2010Hospital of Padova Padua Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crim\u00ec","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED Endocrine Unit Padua Italy"},{"name":"Institute of Radiology, University\u2010Hospital of Padova Padua Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Barbot","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED Endocrine Unit Padua Italy"},{"name":"Endocrine Unit, University\u2010Hospital of Padova Padua Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6946-9673","authenticated-orcid":false,"given":"Simona","family":"Censi","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED Endocrine Unit Padua Italy"},{"name":"Endocrine Unit, University\u2010Hospital of Padova Padua Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sabbadin","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED Endocrine Unit Padua Italy"},{"name":"Endocrine Unit, University\u2010Hospital of Padova Padua Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[{"name":"Department of Medicine DIMED Endocrine Unit Padua Italy"},{"name":"Endocrine Unit, University\u2010Hospital of Padova Padua Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"e_1_2_10_3_1","volume-title":"Secondary Diabetes Mellitus Due to Primary Aldosteronism","author":"Moustaki M.","year":"2023"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00210-2"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3934"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1733"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280108e6f"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.565714"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2009.206"},{"key":"e_1_2_10_10_1","doi-asserted-by":"crossref","unstructured":"M.Buonafine B.Bonnard andF.Jaisser \u201cMineralocorticoid Receptor and Cardiovascular Disease \u201d2018 https:\/\/doi.org\/10.1093\/ajh\/hpy120.","DOI":"10.1093\/ajh\/hpy120"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.02.065"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.312"},{"key":"e_1_2_10_13_1","volume-title":"A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature","author":"Rinella M. E.","year":"2023"},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","unstructured":"T.Kawaguchi T.Tsutsumi D.Nakano M.Eslam J.George andT.Torimura MAFLD Enhances Clinical Practice for Liver Disease in the Asia\u2010Pacific Region 2022 https:\/\/doi.org\/10.3350\/cmh.2021.0310.","DOI":"10.3350\/cmh.2021.0310"},{"key":"e_1_2_10_15_1","volume-title":"MAFLD: Renovation of Clinical Practice and Disease Awareness of Fatty Liver","author":"Kawaguchi T.","year":"2022"},{"key":"e_1_2_10_16_1","volume-title":"A New Definition for Metabolic Dysfunction\u2010Associated Fatty Liver Disease: An International Expert Consensus Statement","author":"Eslam M.","year":"2020"},{"key":"e_1_2_10_17_1","unstructured":"F.Ceccato \u201cPrevalence of Metabolic\u2010Associated Fatty Liver Disease in Patients With Primary Aldosteronism.\u201d Repository Data of the University of Padova Accessed 09 February2025 https:\/\/doi.org\/10.25430\/researchdata.cab.unipd.it.00001274https:\/\/researchdata.cab.unipd.it\/id\/eprint\/1490."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30135-3"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01197-6"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.5152\/AnatolJCardiol.2022.1787"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12330"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000140499.23683.0D"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2022.07.014"},{"key":"e_1_2_10_25_1","volume-title":"Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight","author":"Bioletto F.","year":"2022"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0450"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70242-8"},{"key":"e_1_2_10_28_1","volume-title":"Endocrine Aspects of Metabolic Dysfunction\u2010Associated Steatotic Liver Disease (MASLD): Beyond Insulin Resistance","author":"Hutchison A. L.","year":"2023"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00194"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2814-8"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30319-4"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00321"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00100-0"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01807-3"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13922"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp191"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490543"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00299"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8122194"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15013"},{"key":"e_1_2_10_41_1","doi-asserted-by":"crossref","unstructured":"L.Rahimi A.Rajpal andF.Ismail\u2010Beigi \u201cGlucocorticoid\u2010Induced Fatty Liver Disease \u201d2020 https:\/\/doi.org\/10.2147\/DMSO.S247379.","DOI":"10.2147\/DMSO.S247379"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae568"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.15231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:31:51Z","timestamp":1746189111000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.15231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1111\/cen.15231"],"URL":"https:\/\/doi.org\/10.1111\/cen.15231","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"2024-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}